Rebleeding risk rises with transfusions for patients with NVUGIB

01/31/2013 | Healio

A study published in Alimentary Pharmacology & Therapeutics linked red blood cell transfusions with increased rebleeding risk in patients with nonvariceal upper gastrointestinal bleeding. Transfusions also were associated with greater all-cause mortality. The study of 1,677 patients was limited, according to researchers, but the findings "support the need for a prospective randomized trial."

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA